Sojournix Stock

sojournixpharma.comHealthcare / BioTech & PharmaFounded: 1900Funding to Date: $71.39MM

Sojournix is a clinical stage biopharmaceutical company focused on developing and commercializing novel therapies for the treatment of women’s health and neuroendocrine disorders.

Register To Buy and Sell Shares

For more details on financing and valuation for Sojournix, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Sojournix’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Sojournix.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Scott Rakestraw
Board Member & Co-Founder
Daniel Grau
Co-Founder, President, Chief Executive Officer, and Director

Board Members

Martin Freed MD
Peter Kolchinsky
Daniel Grau
Scott Rakestraw
Aaron Davis
Tavistock Group
Peter Lanciano

Frequently Asked Questions About Sojournix’s Stock

Can you buy Sojournix’s stock?
Sojournix is not publicly traded on NYSE or NASDAQ in the U.S. To buy Sojournix’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Sojournix’s stock?
Yes, you can sell stock of a private company like Sojournix. Forge can help you sell your Sojournix stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Sojournix’s stock price?
Sojournix is a privately held company and therefore does not have a public stock price. However, you may access Sojournix’s private market stock price with Forge Data.
What is Sojournix’s stock ticker symbol?
Sojournix does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Sojournix Completes $44M Series C Financing | FinSMEs
Sojournix, a developer of new medicines for the treatment of women's health and neuroendocrine disorders, completed a $44m Series C financing
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.